Quarterly reports - 17 News by Merck for the chemistry industry

Quarterly reports - 17 News by Merck for the chemistry industry

image description

Merck returns to organic sales growth

Merck raises guidance for 2024

02-Aug-2024 - Merck returned to organic sales growth in the second quarter of 2024. EBITDApre remained around stable organically compared with the year-earlier figure, which had been increased by one-time effects. Excluding these one-time effects in the year-earlier quarter, EBITDApre would also have grown ...

quarterly reports
image description

Merck off to a Good Start in Fiscal 2024

The positive development of Healthcare and Electronics largely compensated for the decline in Life Science

15-May-2024 - Merck has had a good start to fiscal 2024. The Healthcare business sector performed strongly. Electronics also delivered solid organic sales growth, mainly driven by Semiconductor Solutions. Life Science recorded sales and earnings declines compared with the particularly high base of the ...

quarterly reports
image description

Merck Confirms Forecast for Fiscal 2023 Despite Difficult Market Environment in Q3

Return to organic sales growth expected in 2024

10-Nov-2023 - Merck confirmed its forecast for fiscal 2023 despite a difficult market environment in the third quarter. The strong organic development of the Healthcare business sector partly compensated for the decline in sales and earnings in Life Science and Electronics. Once again, Merck benefited from its ...

quarterly reports
image description

Q1 Results: Merck Benefits from Global Diversification in a Challenging Environment

Medium-term structural growth drivers intact

12-May-2023 - Merck generated net sales of €5.3billion in the first quarter of 2023. This corresponds to an increase of 1.8% over the year-earlier quarter (organically 0.8%). Sales growth was in particular attributable to Healthcare, which delivered significant increases in its business with new medicines, ...

quarterly reports
image description

Merck Confirms Guidance for 2022 and Delivers Strong Organic Growth in Q3

Merck continued to grow despite a challenging external operating environment

10-Nov-2022 - Group sales increased by 16.8% to €5,806 million. The “Big 3” – Process Solutions and Life Science Services, new Healthcare products as well as Semiconductor Solutions – were the key drivers of the strong, 7.1% organic increase in sales. Despite higher costs for raw materials, energy and ...

quarterly reports
image description

Merck Delivers Strong First Quarter

High margins in all three businesses despite challenging economic headwinds and increasing global uncertainty

12-May-2022 - Merck achieved strong results in the first quarter of 2022. Net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter. All three business sectors contributed to this growth. The key drivers were the company’s Big3 businesses – the Process Solutions business of Life ...

quarterly reports
image description

Merck: “Big 3” Again Deliver Efficient, Double-Digit Growth

Group net sales rise by 11.8% to € 5.0 billion

11-Nov-2021 - Merck again grew strongly in the third quarter of 2021. Group net sales amounted to €5.0billion. EBITDA pre, the most important financial indicator to steer operating business, reached €1.6billion. Compared with the year-earlier quarter, Group net sales increased by 11.8%. EBITDA pre ...

quarterly reports
image description

Merck achieved strong business results in the first quarter

Organic sales growth of 12.2% driven by all three business sectors, especially Life Science

12-May-2021 - Merck achieved strong business results in the first quarter. Group sales increased by 6.0% to € 4.6 billion compared with the year-earlier quarter – mainly thanks to the high organic growth of the Life Science business sector. Group EBITDA pre, the company’s most important financial indicator ...

quarterly reports
image description

Merck Reports Strong Third Quarter

In comparison with the year-earlier quarter, Group net sales increased by 9.7% to € 4.4 billion

12-Nov-2020 - Merck grew significantly in the third quarter. In comparison with the year-earlier quarter, Group net sales increased by 9.7% to € 4.4 billion. The increase was primarily due to double-digit percentage organic growth in the Life Science business sector and acquisition-related increases in the ...

quarterly reports
image description

Merck Remains on Course in a Challenging Environment

Healthcare and Performance Materials more strongly affected by the Covid-19 pandemic than Life Science

06-Aug-2020 - Merck registered the effects of the Covid-19 pandemic in all business sectors in the second quarter. Healthcare and Performance Materials were affected most strongly. In comparison with the year-earlier quarter, Group sales increased by 3.7% to € 4.1 billion. EBITDA pre, the Group’s most ...

quarterly reports coronaviruses
Search all
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 27,211 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now